 |
|
|
| |
Comparable Risk of Cardiovascular Events in Chronic Hepatitis B Patients Treated with Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide
|
| |
| |
EASL 2023 Vienna June 21-24
Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee and Jonggi Choi Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
|
| |
|
|
|
|
|
